SCHEMBL25355111

SCHEMBL25355111

CCOC(=O)C(=CNc1cc(F)c(Br)c(OC)c1)C(=O)OCC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 5/20 0.51
NPSR1 Q6W5P4 5/20 0.49
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
MAPT P10636 6/20 0.44
KDM4E B2RXH2 6/20 0.44
TDP1 Q9NUW8 2/20 0.44
GAA P10253 4/20 0.43
LMNA P02545 2/20 0.42
MAPK1 P28482 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
PLIN1 O60240 1/20 0.40
POLB P06746 1/20 0.40
PLIN5 Q00G26 1/20 0.40
ABHD5 Q8WTS1 1/20 0.40
RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25357063 0.90 DHODH (0.58) DHODHNPSR1MEN1KMT2AMAPT
SCHEMBL14845097 0.86 DHODH (0.52) DHODHNPSR1MEN1KMT2AMAPT
SCHEMBL25999700 0.84 DHODH (0.52) DHODHNPSR1MEN1KMT2AMAPT
SCHEMBL29550233 0.83 GAA (0.36) MEN1KMT2AMAPTKDM4EGAA
SCHEMBL2968074 0.82 DHODH (0.60) DHODHNPSR1MEN1KMT2AMAPT
SCHEMBL18988001 0.82 DHODH (0.60) DHODHNPSR1MEN1KMT2AMAPT
SCHEMBL20704761 0.82 DHODH (0.58) DHODHNPSR1MEN1KMT2AMAPT
SCHEMBL1345002 0.82 DHODH (0.61) DHODHNPSR1MEN1KMT2AMAPT
SCHEMBL29705221 0.79 DHODH (0.62) DHODHNPSR1MEN1KMT2AMAPT
SCHEMBL17241561 0.79 DHODH (0.62) DHODHNPSR1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240294545-A1 A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD (CN) 2024-09-05 US disclosed
EP-4219499-A1 A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CN) 2023-08-02 EP disclosed
EP-4219499-A1 A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CN) 2023-08-02 EP disclosed
CN-116322699-A Parallel ring compound and preparation and application thereof 石药集团中奇制药技术(石家庄)有限公司 2023-06-23 CN disclosed
WO-2022063303-A1 A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF 石药集团中奇制药技术(石家庄)有限公司 2022-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294545-A1 A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF ATM, CHEK2, CHEK1 DHODH 2948/4885NPSR1 4621/4885MEN1 1511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.